BIOPHYTIS S.A. Biophytis S.A. Share Price Euronext Paris
Equities
ALBPS
FR0012816825
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.85 EUR | 0.00% |
|
+1.19% | -58.33% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | - | Sales 2023 | - | Capitalization | 36.35L 33.69L 30Cr |
|---|---|---|---|---|---|
| Net income 2022 | -2.4Cr -2.22Cr -200.31Cr | Net income 2023 | -1.7Cr -1.58Cr -141.88Cr | EV / Sales 2022 | - |
| Net Debt 2022 | 35.27L 32.69L 29Cr | Net Debt 2023 | 27.03L 25.05L 23Cr | EV / Sales 2023 | - |
| P/E ratio 2022 |
-0.33
x | P/E ratio 2023 |
-0.16
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.58% |
More Fundamentals
* Assessed data
Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19.
The company is located in Paris, France and Cambridge, Massachusetts.
Calendar
29/10/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +5.66% | 11TCr | |
| +11.23% | 11TCr | |
| -0.38% | 2.23TCr | |
| -12.15% | 2.21TCr | |
| -7.66% | 1.87TCr | |
| -36.52% | 1.76TCr | |
| -10.09% | 1.69TCr | |
| +3.33% | 1.38TCr | |
| +36.58% | 1.25TCr |
- Stock Market
- Equities
- ALBPS Stock
- ALBPS Stock
